News Search

Showing 1 - 10 of 114 results.

New Omicron offshoot BA.4.6 evades protection of Evusheld's antibodies, study finds

Source:

CNNhealth

September 7, 2022

BA.4.6 is now causing an estimated 7% to 10% of new Covid-19 infections, according to data from the US Centers for Disease Control and Prevention.
To Avoid Paxlovid Rebound, Some Experts Call for Longer Courses of Treatment

Source:

Time

August 11, 2022

Paxlovid’s rebounds happened in 1-2% of patients. Should people take Paxlovid for longer periods of time to avoid rebound infections?
Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug

Source:

ScienceInsider

June 29, 2022

Lab studies identify resistance mutations in SARS-CoV-2’s protease, and some circulating variants have them
Columbia Scientists Join Consortium to Develop New Antivirals for SARS-CoV-2 and Emerging Viruses

Source:

Columbia University News

June 27, 2022

Scientists at Columbia University have joined a regional consortium of academic and industry partners to accelerate the development of new drugs that target SARS-CoV-2.
COVID-19 rebound a reality after antivirals

Source:

China Daily

June 22, 2022

Reports of people experiencing a COVID-19 rebound after taking the antiviral treatment Paxlovid
New variants will keep COVID-19 circulating at high levels throughout the summer, experts say

Source:

KCRA

June 5, 2022

The newer omicron subvariants BA.4 and BA.5 together are accounted for an estimated 6% to 7% of new infections in the U.S. in late May.
Rebound Covid Infections: Some Contagious Even After Taking Antiviral Paxlovid, Paper Suggests

Source:

Forbes

May 31, 2022

CDC issues new guidance on the antiviral therapy medication Paxlovid.
Here’s What Scientists Know About Paxlovid Rebound

Source:

Time

May 31, 2022

FDA and CDC recommend Paxlovid for people at higher risk of severe COVID-19, including seniors.
CDC warns of COVID-19 "rebound" after taking Paxlovid, but says drug still beneficial

Source:

CBS Evening News

May 31, 2022

CDC is warning of potential "COVID-19 rebound" after a five-day course of the Paxlovid treatment.
Are COVID surges becoming more predictable? New Omicron variants offer a hint

Source:

nature

May 6, 2022

Omicron relatives called BA.4 and BA.5 are behind a fresh wave of COVID-19 in South Africa, and could be signs of a more predictable future for SARS-CoV-2.

News Search

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Source:

Pages